Dutch, UK and US professionals' perceptions of screening for Barrett's esophagus and esophageal adenocarcinoma: a concept mapping study

被引:0
作者
Sijben, Jasmijn [1 ]
Rainey, Linda [2 ]
Peters, Yonne [1 ]
Fitzgerald, Rebecca C. [3 ]
Wani, Sachin [4 ]
Kolb, Jennifer M. [5 ]
Broeders, Mireille J. M. [2 ,6 ]
Siersema, Peter D. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Route 455,Geert Grootepl Zuid 8, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands
[3] Univ Cambridge, Early Canc Inst, Cambridge, England
[4] Univ Colorado, Anschutz Med Ctr, Div Gastroenterol & Hepatol, Aurora, CO USA
[5] UCLA, David Geffen Sch Med, Div Gastroenterol Hepatol & Parenteral Nutr, VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA
[6] Dutch Expert Ctr Screening, Nijmegen, Netherlands
关键词
Barrett's esophagus; Esophageal adenocarcinoma; Early cancer diagnosis; Screening; Physician's practice patterns; MANAGEMENT; DIAGNOSIS; CARE; SURVEILLANCE; GUIDELINE; CANCER; GERD;
D O I
10.1186/s12885-023-11583-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundNovel, less-invasive technologies to screen for Barrett's esophagus (BE) may enable a paradigm shift in early detection strategies for esophageal adenocarcinoma (EAC). Understanding professionals' perspectives on screening is important to determine how to proceed. We aimed to explore and compare professionals' perceptions of screening for BE and EAC screening in three countries.MethodsIn this study, 29 Dutch, 20 British and 18 American health care professionals (clinicians, researchers and policy makers) participated in concept mapping: a mixed-methods consensus building methodology. Statements on perceived barriers, facilitators, advantages, disadvantages, implications or worries associated with screening for BE and EAC were collected in asynchronous digital brainstorm sessions. Subsequently, participants sorted the statements into groups according to thematic similarity and assessed the relevance of each statement in evaluating the acceptability of BE and EAC screening. Multidimensional scaling and cluster analysis were used to map the associations between generated statements.ResultsProfessionals across three countries identified eight consistent themes that relate to their perceptions of screening for BE and EAC: (1) Benefits, (2) Harms, (3) Clinical effectiveness concerns, (4) Screening population, (5) Screening modality, (6) Resources, (7) Ownership, and (8) Public communication. Dutch and American professionals prioritized the potential health benefits of screening but also questioned clinical impact. In contrast, British participants prioritized identification of the screening population and suitable test.ConclusionsMost professionals see potential in less-invasive screening tests for BE and EAC but underline the need to define the target screening population and determine benefits and harms before widely employing them. Successful implementation will require thoughtful consideration of the involvement of general practitioners, readiness of endoscopy and pathology services, balanced public communication, and country-specific regulations.
引用
收藏
页数:13
相关论文
共 50 条
[31]   Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma [J].
Agarwal, Archana ;
Polineni, Rahul ;
Hussein, Zulfiqar ;
Vigoda, Ivette ;
Bhagat, Tushar D. ;
Bhattacharyya, Sanchari ;
Maitra, Anirban ;
Verma, Amit .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2012, 5 (05) :382-396
[32]   Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma [J].
Fang, Yu ;
Chen, Xiaoxin ;
Bajpai, Manisha ;
Verma, Amit ;
Das, Kiron M. ;
Souza, Rhonda F. ;
Garman, Katherine S. ;
Donohoe, Claire L. ;
O'Farrell, Naoimh J. ;
Reynolds, John V. ;
Dvorak, Katerina .
11TH OESO WORLD CONFERENCE: REFLUX DISEASE, 2013, 1300 :187-199
[33]   Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's Esophagus [J].
Wolf, W. Asher ;
Pasricha, Sarina ;
Cotton, Cary ;
Li, Nan ;
Triadafilopoulos, George ;
Muthusamy, V. Raman ;
Chmielewski, Gary W. ;
Corbett, F. Scott ;
Camara, Daniel S. ;
Lightdale, Charles J. ;
Wolfsen, Herbert ;
Chang, Kenneth J. ;
Overholt, Bergein F. ;
Pruitt, Ron E. ;
Ertan, Atilla ;
Komanduri, Srinadh ;
Infantolino, Anthony ;
Rothstein, Richard I. ;
Shaheen, Nicholas J. .
GASTROENTEROLOGY, 2015, 149 (07) :1752-+
[34]   Challenges in Determining the Role of Microbiome Evolution in Barrett's Esophagus and Progression to Esophageal Adenocarcinoma [J].
Guccione, Caitlin ;
Yadlapati, Rena ;
Shah, Shailja ;
Knight, Rob ;
Curtius, Kit .
MICROORGANISMS, 2021, 9 (10)
[35]   Barrett's Esophagus and Esophageal Adenocarcinoma Are Common After Treatment for Achalasia [J].
Leeuwenburgh, I. ;
Scholten, P. ;
Calje, T. J. ;
Vaessen, R. J. ;
Tilanus, H. W. ;
Hansen, B. E. ;
Kuipers, E. J. .
DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (01) :244-252
[36]   Telomere Shortening of Barrett's Esophagus and Esophageal Adenocarcinoma in Japanese Patients [J].
Tahara, Tomomitsu ;
Shijimaya, Takuya ;
Yamazaki, Jumpei ;
Tomiyama, Takashi ;
Fukui, Toshiro ;
Naganuma, Makoto .
CANCER INVESTIGATION, 2023, 41 (07) :640-645
[37]   Barrett’s Esophagus and Esophageal Adenocarcinoma Are Common After Treatment for Achalasia [J].
I. Leeuwenburgh ;
P. Scholten ;
T. J. Caljé ;
R. J. Vaessen ;
H. W. Tilanus ;
B. E. Hansen ;
E. J. Kuipers .
Digestive Diseases and Sciences, 2013, 58 :244-252
[38]   Barrett's Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma [J].
Amlashi, Fatemeh G. ;
Wang, Xuemei ;
Davila, Raquel E. ;
Maru, Dipen M. ;
Bhutani, Manoop S. ;
Lee, Jeffrey H. ;
Weston, Brian R. ;
Kaya, Dilsa Mizrak ;
Vassilakopoulou, Maria ;
Harada, Kazuto ;
Murphy, Mariela A. Blum ;
Rice, David C. ;
Hofstetter, Wayne L. ;
Davila, Marta ;
Nguyen, Quynh-nhu ;
Ajani, Jaffer A. .
ONCOLOGY, 2018, 95 (02) :81-90
[39]   Chemoprevention in Barrett's esophagus and esophageal adenocarcinoma [J].
Alkhayyat, Motasem ;
Kumar, Prabhat ;
Sanaka, Krishna O. ;
Thota, Prashanthi N. .
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
[40]   MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma [J].
Kan, Takatsugu ;
Meltzer, Stephen J. .
CURRENT OPINION IN PHARMACOLOGY, 2009, 9 (06) :727-732